CD44 is a nexus between prognosis and therapeutics for brain cancer management

Linhan Cai, Xinyu Lv, Yiming Chen, Xiaofeng Dai. CD44 is a nexus between prognosis and therapeutics for brain cancer management. Comp. in Bio. and Med., 189:109869, 2025. [doi]

Authors

Linhan Cai

This author has not been identified. Look up 'Linhan Cai' in Google

Xinyu Lv

This author has not been identified. Look up 'Xinyu Lv' in Google

Yiming Chen

This author has not been identified. Look up 'Yiming Chen' in Google

Xiaofeng Dai

This author has not been identified. Look up 'Xiaofeng Dai' in Google